Some cookies are essential to the running of the website, while others (analytics) help us to make improvements. We also incorporate functionality from other websites, such as video, social media feeds and ReachDeck (text-to-speech and translations services) which may set cookies. More on how we use cookies
This website uses text-to-speech software called ReachDeck to read and / or translate its content. To use ReachDeck, you must allow ReachDeck cookies; the ReachDeck icon will then appear at the bottom of your screen.
You can find out more about how ReachDeck uses cookies or change your cookie preferences at any time by going to our cookies page.
Allow ReachDeck cookies Do not use ReachDeck
This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.
The Oxford University Hospitals in partnership with the University of Oxford is a Comprehensive Biomedical Research Centre, funded by the Department of Health to fast-track research into clinical care. Cancer is one of the main research programmes and it receives significant NHS funding.
Many of our clinicians are involved in leading edge research to ensure that breakthroughs in the laboratory bring about clinical benefits as soon as possible.
Cancer Research UK, the Medical Research Council (MRC) and the University of Oxford have made major investments on the Churchill site, including the new Cancer Research Institute and the Radiobiology Research Institute.
Research is carried out into the diagnosis and treatment of a wide range of cancers. Where appropriate, patients are invited to take part in clinical trials under carefully monitored conditions.
Patients who come to the Oxford Cancer and Haematology Centre have rapid access to new treatments and procedures and the opportunity to take part in clinical trials.
The Centre includes dedicated inpatient beds for patients who choose to be involved in these trials.